Hinge Health expands HingeSelect to cover orthopedic surgery, completing an end-to-end musculoskeletal care platform that cuts surgical costs 30–50% and post-op complications by 21%.
- HingeSelect now spans physical therapy through orthopedic surgery and recovery across 4,100+ provider locations nationwide.
- Surgical procedures are priced 30–50% below standard commercial costs; post-surgical complications drop 21% with digitally delivered perioperative care.
- Hinge Health (NYSE: HNGE) posted $182M in Q1 2026 revenue, up 47% year-over-year, with gross margin expanding to 85%, as the full-continuum MSK strategy matures.
Lead
Hinge Health (NYSE: HNGE) announced on June 10, 2026, the addition of orthopedic surgery to its HingeSelect platform, extending the digital musculoskeletal specialist's offering from first-line physical therapy through surgical intervention and post-operative recovery — a full-continuum MSK model the company describes as the first of its kind among digital health vendors focused on musculoskeletal care.What Happened
HingeSelect, launched in mid-2025 as a high-performance provider network for musculoskeletal care, previously covered physical therapy, specialist evaluations, imaging, and non-surgical procedures. The surgery addition layers in prehabilitation, orthopedic surgery, and post-operative rehabilitation, connecting employer-sponsored members to a network now spanning more than 4,100 provider locations.
The platform guides members through a structured pathway: conservative first-line treatment and orthopedic evaluation determine whether surgery is appropriate before any procedure is authorized. When surgery is indicated, HingeSelect coordinates pre-operative preparation, surgeon selection within the network, and full recovery support. That sequencing is central to the company's utilization argument — HingeSelect has reduced combined imaging and surgery utilization by more than 60% relative to commercial benchmarks by ensuring patients exhaust appropriate non-surgical options before reaching the operating room.
"We now provide an end-to-end MSK solution that addresses the entire care journey, not just one part of it," said Daniel Perez, Co-Founder and Chief Executive Officer of Hinge Health.
Clinical and Cost Case
Surgery represents roughly half of all musculoskeletal costs for self-insured employers and commercial payers. An orthopedic procedure occurs every few seconds across the United States, yet evidence suggests up to 50% may not be medically necessary — a persistent source of clinical harm and financial waste that HingeSelect's conservative-first design targets directly.
For cases where surgery is clinically appropriate, HingeSelect prices procedures at 30% to 50% below standard commercial rates. Digitally delivered perioperative physical therapy — beginning before surgery and continuing through recovery — reduces post-surgical complications by 21%, cutting downstream acute-care costs while improving return-to-function timelines. Katie Kirkland, Director of Benefits and Wellbeing at Southern Company, described the expanded platform as "one seamless solution" that removes the coordination burden employers face when managing employees across fragmented orthopedic, physical therapy, and surgical benefit lines.
Strategic Context
The Hinge Health surgery expansion deepens the company's pivot from a point solution — best known for its AI-guided exercise therapy app — toward a comprehensive digital health platform competing for primary MSK benefit-management contracts. Employers historically managed physical therapy, specialist networks, imaging, and surgical benefits through separate vendors, generating clinical discontinuities and administrative overhead. Full-continuum ownership gives Hinge Health a structural cost and quality argument that narrower competitors cannot match.
Hinge Health listed on the New York Stock Exchange in May 2025 at $32 per share. Shares trade near $62, implying a market capitalization of approximately $4.8 billion — nearly double the IPO price, reflecting the market's confidence in the integrated care model. Q1 2026 revenue reached $182 million, a 47% year-over-year increase, with gross margin widening to 85% from 81% — metrics that underscore the scalability of the software-led delivery model even as clinical scope expands.
What Comes Next
The surgery addition positions HingeSelect MSK for the next major employer contracting cycle, as large self-insured buyers and health plans consolidate benefit vendors. Network depth — currently more than 4,100 locations — will be a key competitive variable as Hinge Health scales nationally. Regulatory and clinical scrutiny of surgical appropriateness criteria represents a watch point: the company's utilization-reduction claims rest on the rigor of its pre-surgical evaluation protocols, which will face independent validation as the program scales.
Outlook
Hinge Health's surgery addition to HingeSelect marks the completion of a full musculoskeletal care stack — from first-line exercise therapy through orthopedic surgery and recovery — that no digital-first vendor has previously assembled at comparable scale. With surgical costs materially below commercial benchmarks, demonstrated reductions in unnecessary utilization, and a maturing financial profile anchored by 47% revenue growth, the company enters the second half of 2026 positioned to capture the largest single cost driver in employer health benefits.





